InterventionsHuman trial

Metabolic Response to Oral Semaglutide in Adults with Obesity—Weight Loss and Beyond: The GAROS Prospective Study

ADA Scientific Sessions 2026 Abstract

The paper

SZCZERBINSKI L, KONOPKA P, JANUCIK A et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 3093-LB

doi.org/10.2337/db26-3093-lb

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026